$AMLN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in AMYLIN PHARMACEUTICALS INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in AMYLIN PHARMACEUTICALS INC. Get notifications about new insider transactions in AMYLIN PHARMACEUTICALS INC for free.

Page: < prev 1 2 3 4 5 6 7 8 ... 18 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 24 2012	AMLN	AMYLIN PHARMACEUTI ...	Marshall Paul	SVP, Operations	Grant	A	0.00	15,000	0	27,361	12.4 K to 27.4 K (+121.35 %)
Feb 24 2012	AMLN	AMYLIN PHARMACEUTI ...	Lloyd Marcea Bland	SVP, Chief Administ ...	Sell	S	17.03	7,518	128,033	52,043	59.6 K to 52 K (-12.62 %)
Feb 24 2012	AMLN	AMYLIN PHARMACEUTI ...	Lloyd Marcea Bland	SVP, Chief Administ ...	Grant	A	0.00	20,000	0	59,561	39.6 K to 59.6 K (+50.55 %)
Feb 24 2012	AMLN	AMYLIN PHARMACEUTI ...	Lloyd Marcea Bland	SVP, Chief Administ ...	Sell	S	16.62	5,653	93,927	39,561	45.2 K to 39.6 K (-12.50 %)
Feb 24 2012	AMLN	AMYLIN PHARMACEUTI ...	Lloyd Marcea Bland	SVP, Chief Administ ...	Grant	A	0.00	15,000	0	45,214	30.2 K to 45.2 K (+49.65 %)
Feb 24 2012	AMLN	AMYLIN PHARMACEUTI ...	LEONHARDT HARRY J	SVP, Legal, Complia ...	Sell	S	17.03	2,180	37,126	24,936	27.1 K to 24.9 K (-8.04 %)
Feb 24 2012	AMLN	AMYLIN PHARMACEUTI ...	LEONHARDT HARRY J	SVP, Legal, Complia ...	Grant	A	0.00	5,800	0	27,116	21.3 K to 27.1 K (+27.21 %)
Feb 24 2012	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Sell	S	17.03	5,638	96,016	175,182	180.8 K to 175.2 K (-3.12 %)
Feb 24 2012	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Grant	A	0.00	15,000	0	180,820	165.8 K to 180.8 K (+9.05 %)
Feb 24 2012	AMLN	AMYLIN PHARMACEUTI ...	Gergen Mark J	SVP, Corporate Deve ...	Sell	S	17.03	7,518	128,033	54,826	62.3 K to 54.8 K (-12.06 %)
Feb 24 2012	AMLN	AMYLIN PHARMACEUTI ...	Gergen Mark J	SVP, Corporate Deve ...	Grant	A	0.00	20,000	0	62,344	42.3 K to 62.3 K (+47.23 %)
Feb 24 2012	AMLN	AMYLIN PHARMACEUTI ...	FOLETTA MARK G	SVP, Chief Financia ...	Sell	S	17.03	5,638	96,016	63,439	69.1 K to 63.4 K (-8.16 %)
Feb 24 2012	AMLN	AMYLIN PHARMACEUTI ...	FOLETTA MARK G	SVP, Chief Financia ...	Grant	A	0.00	15,000	0	69,077	54.1 K to 69.1 K (+27.74 %)
Feb 24 2012	AMLN	AMYLIN PHARMACEUTI ...	BRADBURY DANIEL	President & Chief E ...	Option Exercise	A	0.00	100,000	0	133,750
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	Weyer Christian	SVP, Research & Dev ...	Sell	S	16.62	3,843	63,853	20,416	24.3 K to 20.4 K (-15.84 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	Weyer Christian	SVP, Research & Dev ...	Grant	A	0.00	10,000	0	24,259	14.3 K to 24.3 K (+70.13 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	Lloyd Marcea Bland	SVP, Chief Administ ...	Grant	A	15.53	473	7,346	2,087	1.6 K to 2.1 K (+29.31 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Sell	S	16.62	5,637	93,661	165,820	171.5 K to 165.8 K (-3.29 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Grant	A	0.00	15,000	0	171,457	156.5 K to 171.5 K (+9.59 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	LEONHARDT HARRY J	SVP, Legal, Complia ...	Payment of Exercise	F	16.47	2,041	33,615	19,404	21.4 K to 19.4 K (-9.52 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	LEONHARDT HARRY J	SVP, Legal, Complia ...	Grant	A	0.00	5,000	0	21,445	16.4 K to 21.4 K (+30.40 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	Gergen Mark J	SVP, Corporate Deve ...	Payment of Exercise	F	16.47	3,133	51,601	42,344	45.5 K to 42.3 K (-6.89 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	Gergen Mark J	SVP, Corporate Deve ...	Grant	A	0.00	8,000	0	45,477	37.5 K to 45.5 K (+21.35 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	FOLETTA MARK G	SVP, Chief Financia ...	Payment of Exercise	F	16.47	3,122	51,419	54,565	57.7 K to 54.6 K (-5.41 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	FOLETTA MARK G	SVP, Chief Financia ...	Grant	A	0.00	8,000	0	57,687	49.7 K to 57.7 K (+16.10 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	BRADBURY DANIEL	President & Chief E ...	Option Exercise	A	0.00	33,750	0	33,750
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	ROWLAND LLOYD A	VP, Chief Complianc ...	Option Exercise	A	0.00	5,000	0	5,000
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	ROWLAND LLOYD A	VP, Chief Complianc ...	Sell	D	0.00	5,000	0	32,009	37 K to 32 K (-13.51 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	Marshall Paul	SVP, Operations	Payment of Exercise	F	16.47	3,139	51,699	12,361	15.5 K to 12.4 K (-20.25 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	Marshall Paul	SVP, Operations	Grant	A	0.00	8,000	0	15,500	7.5 K to 15.5 K (+106.67 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	Mihalik Vincent P	SVP, Chief Commerci ...	Sell	S	16.62	3,842	63,838	17,175	21 K to 17.2 K (-18.28 %)
Feb 10 2012	AMLN	AMYLIN PHARMACEUTI ...	Mihalik Vincent P	SVP, Chief Commerci ...	Grant	A	0.00	10,000	0	21,017	11 K to 21 K (+90.77 %)
Jan 19 2012	AMLN	AMYLIN PHARMACEUTI ...	BRADBURY DANIEL	President & Chief E ...	Gift	G	11.46	4,538	52,005	20,723	16.2 K to 20.7 K (+28.04 %)
Jan 19 2012	AMLN	AMYLIN PHARMACEUTI ...	BRADBURY DANIEL	President & Chief E ...	Gift	G	11.46	4,538	52,005	36,483	41 K to 36.5 K (-11.06 %)
Jan 19 2012	AMLN	AMYLIN PHARMACEUTI ...	DENNER ALEXANDER J	Director	Option Exercise	M	0.00	1,104	0	0
Jan 19 2012	AMLN	AMYLIN PHARMACEUTI ...	DENNER ALEXANDER J	Director	Option Exercise	M	0.00	4,889	0	1,104
Jan 19 2012	AMLN	AMYLIN PHARMACEUTI ...	DENNER ALEXANDER J	Director	Sell	S	11.59	1,832	21,233	7,161	9 K to 7.2 K (-20.37 %)
Jan 19 2012	AMLN	AMYLIN PHARMACEUTI ...	DENNER ALEXANDER J	Director	Buy	M	0.00	1,104	0	8,993	7.9 K to 9 K (+13.99 %)
Jan 19 2012	AMLN	AMYLIN PHARMACEUTI ...	DENNER ALEXANDER J	Director	Buy	M	0.00	4,889	0	7,889	3 K to 7.9 K (+162.97 %)
Jan 12 2012	AMLN	AMYLIN PHARMACEUTI ...	SULLIVAN JOSEPH P	Director	Option Exercise	A	0.00	1,864	0	24,991
Jan 12 2012	AMLN	AMYLIN PHARMACEUTI ...	CLARK PAUL N	Director	Option Exercise	A	0.00	1,299	0	6,872
Jan 12 2012	AMLN	AMYLIN PHARMACEUTI ...	BECK TERESA	Director	Option Exercise	A	0.00	1,694	0	21,190
Jan 12 2012	AMLN	AMYLIN PHARMACEUTI ...	Lloyd Marcea Bland	SVP, Chief Administ ...	Grant	A	0.00	10,000	0	30,214	20.2 K to 30.2 K (+49.47 %)
Jan 12 2012	AMLN	AMYLIN PHARMACEUTI ...	Gergen Mark J	SVP, Corporate Deve ...	Grant	A	0.00	15,000	0	37,477	22.5 K to 37.5 K (+66.73 %)
Jan 12 2012	AMLN	AMYLIN PHARMACEUTI ...	FOLETTA MARK G	SVP, Chief Financia ...	Grant	A	0.00	7,500	0	49,687	42.2 K to 49.7 K (+17.78 %)
Jan 12 2012	AMLN	AMYLIN PHARMACEUTI ...	BRADBURY DANIEL	President & Chief E ...	Grant	A	0.00	30,000	0	62,178	32.2 K to 62.2 K (+93.23 %)
Oct 14 2011	AMLN	AMYLIN PHARMACEUTI ...	SULLIVAN JOSEPH P	Director	Option Exercise	A	0.00	2,005	0	23,122
Oct 14 2011	AMLN	AMYLIN PHARMACEUTI ...	GAVIN JAMES R III	Director	Option Exercise	A	0.00	615	0	10,189
Oct 14 2011	AMLN	AMYLIN PHARMACEUTI ...	BECK TERESA	Director	Option Exercise	A	0.00	1,823	0	19,494
Oct 14 2011	AMLN	AMYLIN PHARMACEUTI ...	DENNER ALEXANDER J	Director	Option Exercise	A	0.00	1,945	0	5,993
Oct 06 2011	AMLN	AMYLIN PHARMACEUTI ...	BRADBURY DANIEL	President & Chief E ...	Option Exercise	M	5.73	35,624	204,126	0
Oct 06 2011	AMLN	AMYLIN PHARMACEUTI ...	BRADBURY DANIEL	President & Chief E ...	Option Exercise	M	5.73	746	4,275	0
Oct 06 2011	AMLN	AMYLIN PHARMACEUTI ...	BRADBURY DANIEL	President & Chief E ...	Option Exercise	M	5.73	8,630	49,450	746
Oct 06 2011	AMLN	AMYLIN PHARMACEUTI ...	BRADBURY DANIEL	President & Chief E ...	Buy	M	5.73	746	4,275	41,021	40.3 K to 41 K (+1.85 %)
Oct 06 2011	AMLN	AMYLIN PHARMACEUTI ...	BRADBURY DANIEL	President & Chief E ...	Payment of Exercise	F	8.75	5,651	49,446	40,275	45.9 K to 40.3 K (-12.30 %)
Oct 06 2011	AMLN	AMYLIN PHARMACEUTI ...	BRADBURY DANIEL	President & Chief E ...	Buy	M	5.73	8,630	49,450	45,926	37.3 K to 45.9 K (+23.14 %)
Oct 06 2011	AMLN	AMYLIN PHARMACEUTI ...	BRADBURY DANIEL	President & Chief E ...	Payment of Exercise	F	8.75	23,328	204,120	37,296	60.6 K to 37.3 K (-38.48 %)
Oct 06 2011	AMLN	AMYLIN PHARMACEUTI ...	BRADBURY DANIEL	President & Chief E ...	Buy	M	5.73	35,624	204,126	60,624	25 K to 60.6 K (+142.50 %)
Oct 05 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Option Exercise	M	5.73	2,404	13,775	0
Oct 05 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Option Exercise	M	5.73	2,500	14,325	2,404
Oct 05 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Option Exercise	M	5.73	96	550	0
Oct 05 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Option Exercise	M	5.73	12,500	71,625	96
Oct 05 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Payment of Exercise	F	8.75	1,574	13,773	156,457	158 K to 156.5 K (-1.00 %)
Oct 05 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Buy	M	5.73	2,404	13,775	158,031	155.6 K to 158 K (+1.54 %)
Oct 05 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Payment of Exercise	F	8.75	62	543	155,627	155.7 K to 155.6 K (-0.04 %)
Oct 05 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Buy	M	5.73	96	550	155,689	155.6 K to 155.7 K (+0.06 %)
Oct 05 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Sell	S	8.75	2,500	21,871	155,593	158.1 K to 155.6 K (-1.58 %)
Oct 05 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Buy	M	5.73	2,500	14,325	158,093	155.6 K to 158.1 K (+1.61 %)
Oct 05 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Sell	S	8.75	12,500	109,354	155,593	168.1 K to 155.6 K (-7.44 %)
Oct 05 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Buy	M	5.73	12,500	71,625	168,093	155.6 K to 168.1 K (+8.03 %)
Sep 22 2011	AMLN	AMYLIN PHARMACEUTI ...	Marshall Paul	SVP, Operations	Option Exercise	A	10.53	23,931	251,993	23,931
Sep 22 2011	AMLN	AMYLIN PHARMACEUTI ...	Marshall Paul	SVP, Operations	Option Exercise	A	10.53	11,069	116,557	11,069
Sep 22 2011	AMLN	AMYLIN PHARMACEUTI ...	Marshall Paul	SVP, Operations	Grant	A	0.00	7,500	0	7,500	0 to 7.5 K
Aug 19 2011	AMLN	AMYLIN PHARMACEUTI ...	Costa Paulo F	Director	Grant	A	9.90	3,538	35,026	23,000	19.5 K to 23 K (+18.18 %)
Aug 19 2011	AMLN	AMYLIN PHARMACEUTI ...	Costa Paulo F	Director	Grant	A	9.90	4,095	40,538	19,462	15.4 K to 19.5 K (+26.65 %)
Aug 19 2011	AMLN	AMYLIN PHARMACEUTI ...	Costa Paulo F	Director	Grant	A	9.90	1,067	10,563	15,367	14.3 K to 15.4 K (+7.46 %)
Aug 19 2011	AMLN	AMYLIN PHARMACEUTI ...	Costa Paulo F	Director	Grant	A	9.89	1,300	12,857	14,300	13 K to 14.3 K (+10.00 %)
Aug 18 2011	AMLN	AMYLIN PHARMACEUTI ...	Costa Paulo F	Director	Grant	A	10.71	9,900	106,012	13,000	3.1 K to 13 K (+319.35 %)
Aug 18 2011	AMLN	AMYLIN PHARMACEUTI ...	Costa Paulo F	Director	Grant	A	10.71	100	1,071	3,100	3 K to 3.1 K (+3.33 %)
Aug 17 2011	AMLN	AMYLIN PHARMACEUTI ...	ADAMS ADRIAN	Director	Grant	A	10.71	600	6,426	18,000	17.4 K to 18 K (+3.45 %)
Aug 17 2011	AMLN	AMYLIN PHARMACEUTI ...	ADAMS ADRIAN	Director	Grant	A	10.72	1,000	10,720	17,400	16.4 K to 17.4 K (+6.10 %)
Aug 17 2011	AMLN	AMYLIN PHARMACEUTI ...	ADAMS ADRIAN	Director	Grant	A	10.73	2,900	31,117	16,400	13.5 K to 16.4 K (+21.48 %)
Aug 17 2011	AMLN	AMYLIN PHARMACEUTI ...	ADAMS ADRIAN	Director	Grant	A	10.74	100	1,074	13,500	13.4 K to 13.5 K (+0.75 %)
Aug 17 2011	AMLN	AMYLIN PHARMACEUTI ...	ADAMS ADRIAN	Director	Grant	A	10.74	3,800	40,812	13,400	9.6 K to 13.4 K (+39.58 %)
Aug 17 2011	AMLN	AMYLIN PHARMACEUTI ...	ADAMS ADRIAN	Director	Grant	A	10.75	700	7,522	9,600	8.9 K to 9.6 K (+7.87 %)
Aug 17 2011	AMLN	AMYLIN PHARMACEUTI ...	ADAMS ADRIAN	Director	Grant	A	10.75	5,900	63,425	8,900	3 K to 8.9 K (+196.67 %)
Jul 08 2011	AMLN	AMYLIN PHARMACEUTI ...	DENNER ALEXANDER J	Director	Option Exercise	A	0.00	1,487	0	4,049
Jul 07 2011	AMLN	AMYLIN PHARMACEUTI ...	SULLIVAN JOSEPH P	Director	Option Exercise	A	0.00	1,533	0	21,117
Jul 07 2011	AMLN	AMYLIN PHARMACEUTI ...	GAVIN JAMES R III	Director	Option Exercise	A	0.00	471	0	9,574
Jul 07 2011	AMLN	AMYLIN PHARMACEUTI ...	BECK TERESA	Director	Option Exercise	A	0.00	1,394	0	17,671
May 26 2011	AMLN	AMYLIN PHARMACEUTI ...	DENNER ALEXANDER J	Director	Option Exercise	A	13.18	20,000	263,600	20,000
May 26 2011	AMLN	AMYLIN PHARMACEUTI ...	DENNER ALEXANDER J	Director	Grant	A	0.00	3,000	0	3,000	0 to 3 K
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	SULLIVAN JOSEPH P	Director	Option Exercise	A	13.18	20,000	263,600	20,000
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	SULLIVAN JOSEPH P	Director	Grant	A	0.00	3,000	0	3,000	0 to 3 K
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	SKYLER JAY S	Director	Option Exercise	A	13.18	20,000	263,600	20,000
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	SKYLER JAY S	Director	Option Exercise	M	11.03	3,000	33,090	0
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	SKYLER JAY S	Director	Payment of Exercise	F	13.18	2,510	33,082	77,286	79.8 K to 77.3 K (-3.15 %)
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	SKYLER JAY S	Director	Buy	M	11.03	3,000	33,090	79,796	76.8 K to 79.8 K (+3.91 %)
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	SKYLER JAY S	Director	Grant	A	0.00	3,000	0	76,796	73.8 K to 76.8 K (+4.07 %)
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	GAVIN JAMES R III	Director	Option Exercise	A	13.18	20,000	263,600	20,000
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	GAVIN JAMES R III	Director	Grant	A	0.00	3,000	0	4,580	1.6 K to 4.6 K (+189.87 %)
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	EASTHAM KARIN	Director	Option Exercise	A	13.18	20,000	263,600	20,000
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	EASTHAM KARIN	Director	Grant	A	0.00	3,000	0	3,000	0 to 3 K
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	Costa Paulo F	Director	Option Exercise	A	13.18	20,000	263,600	20,000
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	Costa Paulo F	Director	Grant	A	0.00	3,000	0	3,000	0 to 3 K
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	CLARK PAUL N	Director	Option Exercise	A	13.18	20,000	263,600	20,000
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	CLARK PAUL N	Director	Grant	A	0.00	3,000	0	3,000	0 to 3 K
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	BEHRENS M KATHLEEN	Director	Option Exercise	A	13.18	20,000	263,600	20,000
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	BEHRENS M KATHLEEN	Director	Grant	A	0.00	3,000	0	3,000	0 to 3 K
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	BECK TERESA	Director	Option Exercise	A	13.18	20,000	263,600	20,000
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	BECK TERESA	Director	Grant	A	0.00	3,000	0	8,000	5 K to 8 K (+60.00 %)
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	ADAMS ADRIAN	Director	Option Exercise	A	13.18	20,000	263,600	20,000
May 25 2011	AMLN	AMYLIN PHARMACEUTI ...	ADAMS ADRIAN	Director	Grant	A	0.00	3,000	0	3,000	0 to 3 K
Apr 06 2011	AMLN	AMYLIN PHARMACEUTI ...	GAVIN JAMES R III	Director	Option Exercise	A	0.00	568	0	9,103
Apr 06 2011	AMLN	AMYLIN PHARMACEUTI ...	BECK TERESA	Director	Option Exercise	A	0.00	1,682	0	16,277
Apr 06 2011	AMLN	AMYLIN PHARMACEUTI ...	SULLIVAN JOSEPH P	Director	Option Exercise	A	0.00	1,514	0	19,584
Apr 06 2011	AMLN	AMYLIN PHARMACEUTI ...	DENNER ALEXANDER J	Director	Option Exercise	A	0.00	1,457	0	2,562
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	Mihalik Vincent P	SVP, Chief Commerci ...	Option Exercise	A	15.03	33,593	504,903	33,593
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	Mihalik Vincent P	SVP, Chief Commerci ...	Option Exercise	A	15.03	6,407	96,297	6,407
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	Mihalik Vincent P	SVP, Chief Commerci ...	Grant	A	0.00	1,630	0	2,990	1.4 K to 3 K (+119.85 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	Mihalik Vincent P	SVP, Chief Commerci ...	Grant	A	0.00	10,000	0	10,432	432 to 10.4 K (+2,314.81 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	ROWLAND LLOYD A	VP, Chief Complianc ...	Option Exercise	A	15.03	11,000	165,330	11,000
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	ROWLAND LLOYD A	VP, Chief Complianc ...	Option Exercise	A	15.03	5,000	75,150	5,000
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	ROWLAND LLOYD A	VP, Chief Complianc ...	Grant	A	0.00	1,630	0	6,445	4.8 K to 6.4 K (+33.85 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	ROWLAND LLOYD A	VP, Chief Complianc ...	Grant	A	0.00	5,000	0	36,366	31.4 K to 36.4 K (+15.94 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	ROWLAND LLOYD A	VP, Chief Complianc ...	Grant	A	0.00	5,300	0	31,366	26.1 K to 31.4 K (+20.33 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	Lloyd Marcea Bland	SVP, Gov, Corp Affa ...	Option Exercise	A	15.03	52,593	790,473	52,593
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	Lloyd Marcea Bland	SVP, Gov, Corp Affa ...	Option Exercise	A	15.03	7,407	111,327	7,407
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	Lloyd Marcea Bland	SVP, Gov, Corp Affa ...	Grant	A	0.00	1,630	0	6,445	4.8 K to 6.4 K (+33.85 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	Lloyd Marcea Bland	SVP, Gov, Corp Affa ...	Grant	A	0.00	15,000	0	20,214	5.2 K to 20.2 K (+287.69 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	MARCHETTI ROGER	SVP, Human Resource ...	Option Exercise	A	15.03	61,968	931,379	61,968
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	MARCHETTI ROGER	SVP, Human Resource ...	Option Exercise	A	15.03	8,032	120,721	8,032
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	MARCHETTI ROGER	SVP, Human Resource ...	Grant	A	0.00	1,630	0	6,445	4.8 K to 6.4 K (+33.85 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	MARCHETTI ROGER	SVP, Human Resource ...	Grant	A	0.00	15,000	0	22,284	7.3 K to 22.3 K (+205.93 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	Weyer Christian	SVP, Research & Dev ...	Option Exercise	A	15.03	113,027	1,698,796	113,027
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	Weyer Christian	SVP, Research & Dev ...	Option Exercise	A	15.03	11,973	179,954	11,973
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	Weyer Christian	SVP, Research & Dev ...	Grant	A	0.00	1,630	0	6,445	4.8 K to 6.4 K (+33.85 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	Weyer Christian	SVP, Research & Dev ...	Grant	A	0.00	10,000	0	13,483	3.5 K to 13.5 K (+287.11 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	LEONHARDT HARRY J	VP, Legal and Corpo ...	Option Exercise	A	15.03	41,386	622,032	41,386
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	LEONHARDT HARRY J	VP, Legal and Corpo ...	Option Exercise	A	15.03	8,614	129,468	8,614
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	LEONHARDT HARRY J	VP, Legal and Corpo ...	Grant	A	0.00	1,630	0	5,857	4.2 K to 5.9 K (+38.56 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	LEONHARDT HARRY J	VP, Legal and Corpo ...	Grant	A	0.00	10,000	0	16,445	6.4 K to 16.4 K (+155.16 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Option Exercise	A	15.03	19,781	297,308	19,781
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Option Exercise	M	11.13	5,000	55,625	350
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Option Exercise	M	5.73	2,500	14,325	4,904
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Option Exercise	A	15.03	5,219	78,442	5,219
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Option Exercise	M	11.13	6,250	69,531	0
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Grant	A	0.00	1,630	0	6,445	4.8 K to 6.4 K (+33.85 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Sell	S	15.02	6,250	93,859	155,136	161.4 K to 155.1 K (-3.87 %)
Mar 03 2011	AMLN	AMYLIN PHARMACEUTI ...	KOLTERMAN ORVILLE G	SVP, Chief Medical ...	Buy	M	11.13	6,250	69,531	161,386	155.1 K to 161.4 K (+4.03 %)

Page: < prev 1 2 3 4 5 6 7 8 ... 18 next >